maia new clinical presentation

71
1 Confocal Microperimetry: Macular function & Visual Rehabilitation Marco U. Morales Chief Scientific Officer Ophthalmology & Visual Science PhD Program University of Nottingham

Upload: doliem

Post on 09-Jan-2017

219 views

Category:

Documents


4 download

TRANSCRIPT

Page 1: MAIA New Clinical Presentation

1

Confocal Microperimetry:

Macular function &

Visual Rehabilitation

Marco U. Morales Chief Scientific Officer

Ophthalmology & Visual Science PhD Program University of Nottingham

Page 2: MAIA New Clinical Presentation

2

Microperimetry Scope: To analyse vision

Page 3: MAIA New Clinical Presentation

3

Microperimetry Scope: To analyse vision

In patients with macular pathologies

Page 4: MAIA New Clinical Presentation

4

Dry AMD

Wet AMD

Vitelliform Dystrophy Myopic Macular degeneration

CENTRAL VISION LOSS

Page 5: MAIA New Clinical Presentation

5

Page 6: MAIA New Clinical Presentation

6

Page 7: MAIA New Clinical Presentation

7

Page 8: MAIA New Clinical Presentation

8

Page 9: MAIA New Clinical Presentation

9 9

Page 10: MAIA New Clinical Presentation

10 10

Page 11: MAIA New Clinical Presentation

11

RETINAL IMAGING

( SLO )

SENSITIVITY TEST

EYE TRACKING

-eye movement

-fixation information

(PRL)

Micro-Perimetry Concept

11

Page 12: MAIA New Clinical Presentation

12

Micro-Perimetry Concept

RETINAL IMAGING

( SLO )

SENSITIVITY TEST

EYE TRACKING

-eye movement

-fixation information

(PRL)

#

Page 13: MAIA New Clinical Presentation

13

Micro-Perimetry Concept

RETINAL IMAGING

( SLO )

SENSITIVITY TEST

FIXATION ANALYSIS

Fixation Location

&

Fixation Quality

PRL (Preferred Retinal Locus)

Page 14: MAIA New Clinical Presentation

14

Function of the Healthy Macula

Fixation STABLE

Page 15: MAIA New Clinical Presentation

15

Function of the Healthy Macula

Sensitivity Avg > 25 dB

#

Page 16: MAIA New Clinical Presentation

16

Function of the Unhealthy Macula

Sensitivity Avg. < 25 dB

Page 17: MAIA New Clinical Presentation

17

Function of the Unhealthy Macula

% Reduced Threshold to measure localized defects

(maia Integrity Index)

Page 18: MAIA New Clinical Presentation

18

Function of the Unhealthy Macula

Fixation UNSTABLE

Page 19: MAIA New Clinical Presentation

PRL

PRL

PRL

PRL

Different PRL location during the same fixation attempt.

PRL on patients with loss of central vision

19

Page 20: MAIA New Clinical Presentation

Estimated foveal location

Fixation Drift indicates abnormal macular function

20

Page 21: MAIA New Clinical Presentation

Wet AMD Patient

21

Page 22: MAIA New Clinical Presentation

Wet AMD Patient

22

Page 23: MAIA New Clinical Presentation

Fixation points (ploted by the Eye Tracker)

Sensitivity points (dB) (Goldman III stimuli test)

Sensitivity points (dB) (Goldman III stimuli test)

23

Page 24: MAIA New Clinical Presentation

Fixation = Stable If P1 and P2 > 75 % Fixation = Relatively Unstable If P1<75% but P2> 75%, Fixation = Unstable If both P1 and P2 < 75%

Fixation stability is classified as:

24

Page 25: MAIA New Clinical Presentation

25

During the examination, patients are asked to look at the central fixation target in the MAIA microperimetry (1° red circle)

Page 26: MAIA New Clinical Presentation

26

Estimated fovea location

If the fovea is not in good conditions, patients use an extra foveal locus to perceive the fixation target.

PRL initially used to “see” the fixation target

Page 27: MAIA New Clinical Presentation

27

Estimated fovea location

MAIA use the initial PRL ( 10 initial seconds of examination) to automatically center the stimuli grid map on it

Page 28: MAIA New Clinical Presentation

28

Estimated fovea location

During the whole examination the cloud of fixation points are identified and measured by the area known as the Bivariate Contour Ellipse Area (BCEA)

BCEA

Page 29: MAIA New Clinical Presentation

6/17/2015 29

PRL_initial

PRL_ final

Estimated fovea location

At the end of the examination it is easy to recognise both, the initial and the final PRL

Page 30: MAIA New Clinical Presentation

30

Macula Clinic

Eccentric Viewing

Rehabilitation

Cataract Surgery

CLINICAL APPLICATIONS

30

Page 31: MAIA New Clinical Presentation

31

Macula Clinic

Eccentric Viewing

Rehabilitation

Cataract Surgery

CLINICAL APPLICATIONS

31

Page 32: MAIA New Clinical Presentation

Wet AMD Patient

32

Page 33: MAIA New Clinical Presentation

PRL_initial = Foveal

PRL_final = 3.5° Superior

Avg sensitivity central 10° = 14.1 dB

Avg perifoveal sensitivity = 11.4 dB

Is ∆PRLi-f an important prognosis factor?

Morales et al: “PRL profile during prolonged fixation attempt”

33

Page 34: MAIA New Clinical Presentation

34

Macula Clinic

Eccentric Viewing

Rehabilitation

Cataract Surgery

CLINICAL APPLICATIONS

34

Page 35: MAIA New Clinical Presentation

Macular integrity assessment prior cataract surgery

35

Page 36: MAIA New Clinical Presentation

With a slit lamp and fundus camera, it may be difficult to see specific retinal details in presence of cataract.

36

Page 37: MAIA New Clinical Presentation

Thanks to the Scanning Laser Ophthalmoscope confocal technology, early cataracts can be seen reflected as dark shadows over the retina image.

37

Page 38: MAIA New Clinical Presentation

… and in the case of dense cataracts, the SLO confocal technology is able to “see” the retina even up to grade 3+ opacity.

38

Page 39: MAIA New Clinical Presentation

Confocal technology

39

Page 40: MAIA New Clinical Presentation

Confocal technology

40

Page 41: MAIA New Clinical Presentation

Macular Integrity Assessment

in patients with cataract.

Case reports

41

Page 42: MAIA New Clinical Presentation

CASE 2: Male, 80 years old, OD - IOL OS - cataract

MAIA helps with the decision of performing cataract surgery on the fellow eye.

42

Page 43: MAIA New Clinical Presentation

The SLO image on OS shows signs of cataract

OD - IOL OS cataract

CASE 2: Male, 80 years old, OD IOL OS cataract

43

Page 44: MAIA New Clinical Presentation

MAIA shows considerable reduced average macular sensitivity on the IOL-eye (5.7db), although fixation (represented by the blue dots) is highly stable and central.

CASE 2: Male, 80 years old, OD IOL OS cataract

OD - IOL

44

Page 45: MAIA New Clinical Presentation

The sensitivity detail shows low sensitivity on the perifoveal area with dense RING-scotoma on the perimacular area

CASE 2: Male, 80 years old, OD IOL OS cataract

OD - IOL

45

Page 46: MAIA New Clinical Presentation

The MAIA test on the cataract eye (OS) shows higher

macular average sensitivity (16.3 dB) than the fellow

eye, with stable and central fixation (good foveal

function).

CASE 2: Male, 80 years old, OD IOL OS cataract

OS - cataract

46

Page 47: MAIA New Clinical Presentation

The MAIA information helped the surgeon and his patient in the decision to proceed with the cataract surgery on OS.

CASE 2: Male, 80 years old, OD IOL OS cataract

OS - cataract

47

Page 48: MAIA New Clinical Presentation

CASE 3: Female, 81 years old, OD cataract, OS cataract with Geographic Atrophy (GA)

MAIA helps in the decision to perform cataract surgery.

48

Page 49: MAIA New Clinical Presentation

The MAIA test on OD showed relatively good average sensitivity (yellow area) and excellent fixation stability suggesting good prognosis after cataract surgery. In contrary, OS has low retina sensitivity and very unstable fixation suggesting poor BCVA prognosis after surgery.

Fixation stability

Retina sensibility Avg threshold = 11.3dB Retina sensibility Avg. threshold = 20.4 dB

Fixation stability

CASE 3: Female, 81 years old, OD cataract OS cataract + GA

49

Page 50: MAIA New Clinical Presentation

50 50

Page 51: MAIA New Clinical Presentation

51 51

Page 52: MAIA New Clinical Presentation

52 52

Page 53: MAIA New Clinical Presentation

53

Macula Clinic

Eccentric Viewing

Rehabilitation

Cataract Surgery

CLINICAL APPLICATIONS

53

Page 54: MAIA New Clinical Presentation

MAIA in the Low Vision practice is used to

“Relocate PRL with Biofeedback techniques”

The aim is to gain control involuntary bodily function.

54

Page 55: MAIA New Clinical Presentation

What is BioFeedback ?

Biofeedback is a treatment technique in which patients are trained to improve their health by using signals from their own bodies.

Instruments measure physiological activities and “feed-back” such information in real time to create a awareness of their body condition.

55

Page 56: MAIA New Clinical Presentation

The MAIA Biofeedback training

A beep sound guides the patient during the eye movement control exercises.

= patient fixation

= target fixation

56

Page 57: MAIA New Clinical Presentation

PRL OD Before Rehabilitation V.A. = 1.0 LogMAR

(6/60 – 20/200 – 0.10)

PRL OD After Rehabilitation V.A. = 0.60 LogMAR (6/24 – 20/80 – 0.25)

Examples of PRL training with Biofeedback

Severe vision loss Moderate vision loss

57

Page 58: MAIA New Clinical Presentation

Examples of PRL training with Biofeedback

PRL OD Before Rehabilitation V.A. = 0.8 LogMAR

(6/38 – 20/125 – 0.16)

PRL OD After Rehabilitation V.A. = 0.5 LogMAR (6/19 – 20/63 – 0.32)

Moderate vision loss Mild vision loss

58

Page 59: MAIA New Clinical Presentation

Binocular Analysis for PRL rehabilitation

59

Page 60: MAIA New Clinical Presentation

http://casereports.bmj.com/content/2015/bcr-2014-207969.abstract

60

Page 61: MAIA New Clinical Presentation

XV Congresso Nazionale della Low Vision Academy, MILANO, 2014 61

Page 62: MAIA New Clinical Presentation

VA = 1.0 LogMAR (OO)

VA = 0.5 LogMAR (OO)

62

Page 63: MAIA New Clinical Presentation

VA = 1.0 LogMAR (OO)

VA = 0.5 LogMAR (OO)

63

Page 64: MAIA New Clinical Presentation

Analysis of both eyes

64

Page 65: MAIA New Clinical Presentation

XV Congresso Nazionale della Low Vision Academy, MILANO, 2014

OCT to determine the foveal location

65

Page 66: MAIA New Clinical Presentation

Definition of the best PRL Target

66

Page 67: MAIA New Clinical Presentation

Reading Reading

67

Page 68: MAIA New Clinical Presentation

Reading Reading

68

Page 69: MAIA New Clinical Presentation

69

Page 70: MAIA New Clinical Presentation

70

CONCLUSIONS Confocal Microperimetry may be considered as a valuable tool in the evaluation of retinal function, particularly in cases with central scotoma. Microperimetry values of localized retinal sensitivity, fixation stability and fixation location are precise parameters to monitor pathologies progression and may be considered as important prognosis factor for visual therapies. 70